Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2609 results about "Methylation" patented technology

In the chemical sciences, methylation denotes the addition of a methyl group on a substrate, or the substitution of an atom (or group) by a methyl group. Methylation is a form of alkylation, with a methyl group, rather than a larger carbon chain, replacing a hydrogen atom. These terms are commonly used in chemistry, biochemistry, soil science, and the biological sciences.

Quantum and region sensing fused protein methylation site prediction method

ActiveCN120727109ABiostatisticsHybridisationProtein methylationNetwork model
The invention provides a protein methylation site prediction method fusing quantum and region perception, which comprises the following steps: step 1, acquiring a protein sequence as a data source, and respectively constructing a training set and an independent test set; 2, constructing a multi-modal feature for each protein sequence by adopting a three-way nested scattering network, and fusing the multi-modal features to obtain an optimized fusion feature tensor; and step 3, inputting the optimized fusion feature tensor into a RaQMeNet network model, and performing a methylation site prediction task. The performance indexes of the method are greatly superior to those of the prior art, and the method has higher adaptability, stability and interpretability, can be widely applied to a plurality of bioinformatics and biological medicine related fields such as protein function annotation, disease mechanism research and drug target discovery, and has good application prospects and commercial values.
Owner:NANTONG UNIV

Method for editing cattle gene based on Pro-iCHI

The invention belongs to the technical field of molecular biology and genetics, and particularly relates to a method for editing cattle genes based on Pro-iCHI. The invention provides a method for editing cattle genes based on Pro-iCHI, which comprises the following steps: transiently expressing protamine in cattle AG-haESCs after gene editing, and injecting into mature oocytes to obtain reconstructed embryos. The protamine can remove abnormal DNA methylation generated by an oocyte cytoplasm injection haploid stem cell technology, cell nucleuses are compressed into a sperm-like structure, the obtained bovine Pro-iCHI embryo can smoothly develop into a blastocyst, and the ratio of the blastocyst to the blastocyst obtained by in-vitro fertilization is equivalent. Moreover, the protamine coding gene is inserted into the saccharomyces cerevisiae protein expression vector and then is subjected to transient expression, so that the protamine coding gene cannot be integrated into a genome to cause insertion of an exogenous gene while abnormal DNA methylation is erased.
Owner:INNER MONGOLIA UNIVERSITY

Cancer detection and classification using methylome analysis

There is described herein, a method of capturing cell-free methylated DNA from a sample having less than 100 mg of cell-free DNA, comprising the steps of: subjecting the sample to library preparation to permit subsequent sequencing of the cell-free methylated DNA; adding a first amount of filler DNA to the sample, wherein at least a portion of the filler DNA is methylated; denaturing the sample; and capturing cell-free methylated DNA using a binder selective for methylated polynucleotides.
Owner:UNIV HEALTH NETWORK +1

Esophageal cancer marker screening method based on enzyme transfer methylation sequencing

The invention provides an esophageal cancer marker screening method based on enzyme transfer method methylation sequencing, which comprises the following steps: S1, collecting esophageal early cancer and para-carcinoma tissue samples, and carrying out enzyme transfer method whole genome methylation sequencing; s2, integrating methylation data of esophageal cancer and para-carcinoma tissues in databases of TCGA, GEO, MethMarker DB and the like; s3, screening differential methylation sites, preferably sites which are hypermethylated in esophageal cancer but hypomethylated in samples such as leukocytes, so as to reduce plasma background interference; s4, obtaining a candidate marker combination based on an integrated methylation feature screening model of LASSO regression and a random forest algorithm; s5, constructing a classifier model based on the candidate marker combination, carrying out training and reasoning test on the model, and evaluating the prediction performance of the model; and S6, obtaining the esophageal cancer marker combination. According to the method, enzyme transfer sequencing and machine learning are combined, the marker prediction accuracy is remarkably improved, and a new reference is provided for clinical research of esophageal cancer.
Owner:SOUTHEAST UNIV NANJING INST OF BIOMATERIALS & MEDICAL DEVICES

Human body biological age detection method based on DNA methylation

The invention provides a human body biological age detection method based on DNA methylation, which comprises the following steps: step S1, aiming at at least one subject, collecting a peripheral blood sample of the subject, and extracting DNA in blood from the sample; the method comprises the following steps: S1, extracting DNA, S2, measuring a methylation map of the extracted DNA to obtain detailed information of the methylation state of the DNA, and S3, calculating a corresponding methylation rate according to the strength of a methylation signal and a non-methylation signal in the obtained methylation map; and step S4, inputting the calculated DNA methylation rate into a biological age model obtained by pre-training to obtain the biological age corresponding to the subject. The method has the beneficial effects that the biological age can be accurately predicted by acquiring methylation information of DNA data, a novel biomarker-based assessment means is provided, and the method has important application value in health management, disease risk assessment and the like.
Owner:ZHEJIANG GAOMEI GENE TECH CO LTD

Cancer detection and classification using methylome analysis

This is described herein, a method of capturing cell-free methylated DNA from a sample having less than 100 mg of cell-free DNA, comprising the steps of: subjecting the sample to library preparation to permit subsequent sequencing of the cell-free methylated DNA; adding a first amount of filler DNA to the sample, wherein at least a portion of the filler DNA is methylated; denaturing the sample; and capturing cell-free methylated DNA using a binder selective for methylated polynucleotides.
Owner:UNIV HEALTH NETWORK

Synthetic method of water soluble ultraviolet light absorber BP-9

The invention discloses a synthetic method of a water soluble ultraviolet light absorber BP-9. The method mainly comprises the following process steps: (1) carrying out methylation on the main raw materials of 2, 2', 4, 4'-tetrahydroxyl benzophenone, a transition metal salt catalyst and a mixed solvent which is prepared from dichloroethane and anhydrous ethanol in equal parts by weight to obtain 2, 2'-dihydroxyl-4, 4'-dimethoxyl benzophenone; (2) carrying out sulfonation reaction on the main raw materials of methylate, sulfamic acid and C1-C3 halohydrocarbon to obtain 2, 2'-dihydroxyl-4, 4'-dimethoxyl benzophenone-5, 5'-disulfonic acid; and (3) carrying out neutral reaction on the main raw materials of sulfonated product, inorganic base and ethanol water to finally obtain the BP-9 product. The synthetic method disclosed by the invention is few in reaction step, low in cost, high in product purity and stable in quality, and raw materials are easily available.
Owner:HUANGGANG MEIFENG CHEM TECH +1

DNA methylation detection method and device and electronic equipment

The invention relates to a DNA methylation detection method and device and electronic equipment, and the method comprises the following steps: obtaining a DNA sequence to be detected; obtaining original electric signal data and a base sequence corresponding to the DNA sequence to be detected through a nanopore sequencing technology; obtaining a methylation detection result corresponding to the DNA sequence to be detected according to the original electric signal data, the base sequence and a deep learning model; wherein the deep learning model comprises a sequence feature extraction module, a signal feature extraction module, a feature fusion module and a classification module; the sequence feature extraction module comprises a Transform encoder; the signal feature extraction module comprises a Conformer encoder; the feature fusion module comprises a Transform decoder; the classification module comprises a full connection layer; according to the method provided by the invention, the identification accuracy of the methylation site can be improved, high-precision methylation detection is realized, and the problems of gradient disappearance and gradient explosion can be effectively relieved.
Owner:BEIJING POLYSEQ BIOTECH CO LTD +1

Cancer patient gene methylation characteristic screening method based on DQN reinforcement learning

The invention provides a cancer patient gene methylation feature screening method based on DQN reinforcement learning, which converts a gene methylation feature screening problem into a reinforcement learning problem by constructing a deep Q network model, and dynamically selects the most representative methylation feature by taking maximization of prediction accuracy as a target. The method comprises the following steps: firstly, preprocessing gene methylation data of a cancer patient, then continuously optimizing a feature selection strategy in a multi-round training process through a DQN model, and finally screening out key methylation features closely related to cancer diagnosis and prognosis. The method can effectively reduce the feature dimension, improves the generalization ability of the model, and has wide application prospects in early diagnosis, personalized treatment and prognosis evaluation of cancers.
Owner:GUILIN UNIV OF ELECTRONIC TECH

Genomic and methylation biomarkers for prediction of copy number loss / gene deletion

PCT designated stage expiredWO2025076425A1Microbiological testing/measurementCell-Free Nucleic AcidsCell
Disclosed herein are methods, compositions, and devices for use in diagnosis and treatment of cancer. The methods include sequencing a panel of regions in cell-free nucleic acid molecules and detecting one or more biomarkers that are indicative of a cancer.
Owner:GUARDANT HEALTH INC

Methylation detection combined marker based on free DNA in alveolar lavage fluid and application of methylation detection combined marker

The invention provides a methylation detection combined marker based on free DNA (cfDNA) in pulmonary alveolar lavage fluid (BAL) and application of the methylation detection combined marker. The methylation combination marker optimizes methylation detection targets in early screening of lung cancer, reduces detection difficulty and cost, and has high diagnosis accuracy, sensitivity and specificity.
Owner:SUZHOU DUSHU LAKE HOSPITAL (DUSHU LAKE HOSPITAL AFFILIATED TO SOOCHOU UNIV)

Variant calling with methylation-level estimation

PCT designated stage expiredWO2025006565A1BiostatisticsProteomicsCytosineNucleotide
This disclosure describes methods, non-transitory-computer readable media, and systems that can simultaneously determine estimated methylation-level values for cytosine bases and genotype calls for a target genomic sample. The disclosed system can utilize a Bayesian method on a target genomic sample's nucleotide-read data to generate estimated methylation-level values that indicate genomic coordinates at which the target genomic sample comprises a reference cytosine base or a nucleobase that could be called as a cytosine. The disclosed system can estimate methylation-level values based on prior genotype probabilities and observed nucleobases at a genomic coordinate from a read pileup of a target genomic sample. Based on the estimated methylation-level values and base-call-quality metrics, the disclosed system may generate posterior genotype probabilities for the genomic sample at the genomic coordinate. Based on the posterior genotype probabilities, the disclosed system can generate a genotype call for the target genomic sample.
Owner:ILLUMINA INC

Method, combination and kit for detecting malignant pulmonary nodules and lung cancer

The invention provides a minimally invasive method for determining whether pulmonary nodules are malignant or not by measuring methylation levels of different gene combinations such as CDO1, PTGER4, HOXA9, SHOX2, SP9 and ZNF781. The disclosed methods also enable the detection of lung cancer. The invention also discloses a polynucleotide and a kit which can be used for measuring the methylation level of CDO1, PTGER4, HOXA9, SHOX2, SP9 and ZNF781.
Owner:SUZHOU HUHU HEALTH TECH CO LTD

Methylated biomarker for detecting colorectal cancer or colorectal adenoma

The invention relates to a methylation biomarker for detecting colorectal cancer or colorectal adenoma. The methylation biomarker comprises any one gene of SDC2, COL4A2 and C9H9orf50 or any combination of the SDC2, the COL4A2 and the C9H9orf50. Wherein a methylation target detection region of the SDC2 gene is a full-length region of chr8: 96494012-96494130 or a partial region of the full-length region of chr8: 96494012-96494130; a methylation target detection region of the COL4A2 gene is a full-length region of chr13: 110306814-110306983 or a part of the full-length region of the chr13: 110306814-110306983; and the methylation target detection region of the C9H9orf50 gene is the full-length region of chr9: 129620291-129620374 or a part of the full-length region of chr9: 129620291-129620374. According to the kit, methylation signals related to intestinal cancer and adenoma in excrement samples can be more accurately detected through detection in different combination modes of the three markers, the early effective diagnosis rate of colorectal cancer patients can be increased, and therefore the survival rate of the patients is increased, and prognosis is improved.
Owner:ZYBIO INC

Individualized management system and method for colorectal cancer risk prediction

The invention provides an individualized management system and method for colorectal cancer risk prediction, and relates to the technical field of medical diagnosis and individualized medical treatment. The system comprises a multi-omics data processing module used for collecting a blood sample of a subject, extracting circulating free DNA, and sequencing cfDNA by adopting a simplified methylation sequencing technology to obtain final original data of DNA methylation characteristics; the risk prediction module is used for carrying out bioinformatics analysis on the original data of the final DNA methylation features by adopting a machine learning algorithm, extracting a methylation feature set, a tail end motif feature set and a breakpoint motif feature set, and carrying out risk prediction on the basis of the extracted feature sets; and predicting the colorectal cancer disease risk of the subject by using a pre-trained prediction model to obtain a prediction result. The problem that the risk prediction accuracy of the colorectal cancer is low is solved.
Owner:THE AFFILIATED SIR RUN RUN SHAW HOSPITAL OF SCHOOL OF MEDICINE ZHEJIANG UNIV

Formulations for modulating MYC expression

The present disclosure relates to compositions and methods for reducing expression of MYC gene in a cell. In some embodiments, an expression repressor comprises a targeting moiety that binds a MYC promoter, anchor sequence, or super-enhancer. In some embodiments, the expression repressor comprises an effector moiety that represses transcription or methylates DNA. Systems comprising two expression repressors are also disclosed. The compositions can be used, for example, to treat cancers such as HCC.
Owner:ACUITAS THERAPEUTICS INC +1

Methods and systems for generating sequencing libraries

Methods and systems for targeted detection of circulating tumor DNA (ctDNA) molecules are disclosed herein. In some cases, a molecular sequencing library depleted of methylated DNA can be generated and used to detect ctDNA in a cell-free DNA sample reliably at a lower sequencing depth and lower cost than existing methods.
Owner:ADELA INC

Method for carrying out pathogenic microorganism identification and gene variation state joint detection on alveolar lavage fluid sample based on high-throughput sequencing

The invention relates to a method for carrying out pathogenic microorganism identification and gene variation state joint detection on a pulmonary alveolar lavage fluid sample based on high-throughput sequencing. The method comprises the following steps: extracting nucleic acid from the pulmonary alveolar lavage fluid sample; constructing a metagenome capture library, and constructing a lung cancer polygene library; carrying out final library pooling; performing high-throughput sequencing; and analyzing data. Compared with the prior art, the scheme provided by the invention is based on a technical path of'macro 'captured by metagenome and'target' of targeted high-throughput sequencing; after the constructed final library is subjected to high-throughput sequencing and data analysis, index output (pathogenic microorganism identification, host chromosome copy number variation, gene mutation, gene fusion, gene copy number variation and methylation state) of multiple biomarkers can be met in one-time detection.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

Selective oxidation of 5-methylcytosine by TET-family proteins

The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TEM3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.
Owner:CHILDRENS MEDICAL CENT CORP +1

DNA methylation biomarker combination for prostate cancer detection and application of DNA methylation biomarker combination

The invention discloses a DNA methylation biomarker combination for prostate cancer detection and application of the DNA methylation biomarker combination, and belongs to the technical field of biological medicine. The DNA methylation biomarker combination comprises a combination of methylation sites indicated by CG in the SEQ ID NO: 1 sequence of the USP44 gene and the SEQ ID NO: 2 sequence of the HIF3A gene. It is reported for the first time that the methylation levels of the USP44 gene and the HIF3A gene are detected at the same time to conduct auxiliary diagnosis on the prostatic cancer, a sample urine detection result shows that the sensitivity is 97.14%, the specificity is 97.78%, and the non-invasive and reliable prostatic cancer detection method is provided and has good application prospects in early screening of the prostatic cancer.
Owner:WUHAN YZY MEDICAL SCI & TECH

TAGMe-3, a novel DNA methylation marker for tumor identification, and its applications.

The application provides a novel DNA methylation marker TAGMe-3 for tumor identification and use thereof. The TAGMe-3 gene sequence region has significant methylation difference between cancer tissues and paracancer tissues. As long as abnormal high methylation state of the TAGMe-3 gene sequence region is detected, the subject is determined to belong to a tumor high-risk population. Moreover, the significant difference of the TAGMe-3 presented between tumor tissues and non-tumor tissues exists in different types of tumors (Pan-cancer) in a wide range.
Owner:SHANGHAI EPIPROBE BIOTECH CO LTD

Treatment of fragile x syndrome with cannabidiol

The present technology relates to a method of treating one or more symptoms of Full Methylation (Fmet) Fragile X Syndrome in a subject that includes administering an effective amount of cannabidiol to the subject such that one or more symptoms of Fragile X Syndrome are treated.
Owner:HARMONY BIOSCIENCES MANAGEMENT INC

Method for screening and identifying cucumber aphid-resistant gene as well as screened gene and application thereof

The invention discloses a method for screening and identifying a cucumber aphid-resistant gene as well as a screened gene and application thereof, and provides a brand-new method for screening and identifying the cucumber aphid-resistant gene, which is used for screening the cucumber aphid-resistant gene based on four omics technologies. The four types of omics comprise transcriptome, proteome, methylation group and metabolome before and after inoculation of aphids on cucumbers, and the cucumber aphid resistance regulation gene is screened through combined analysis, so that a new gene resource is provided for improving the aphid resistance of the cucumbers, and a new method and a new idea are provided for designing molecular genetic breeding. The CsPGD2 gene obtained through screening is an aphid resistance gene, the dynamic change of a metabolic substance 5-ribulose phosphate in a metabolome is consistent with that of a transcriptome gene CsPGD2, the aphid resistance function of the gene CsPGD2 is verified through VIGS, and the result proves that the gene CsPGD2 is an important regulation factor for the aphid resistance of cucumbers. The invention provides a new gene resource for improving the aphid resistance of cucumbers, and has a good application prospect.
Owner:YANGZHOU UNIV

Deep learning cancer risk prediction method and system based on methylation sequence

The invention relates to the technical field of cancer risk prediction, in particular to a deep learning cancer risk prediction method and system based on a methylation sequence. The method comprises the following steps: acquiring DNA methylation sequencing data and reference genome annotation data in a blood sample of a cancer patient; performing functional region classification processing on the DNA methylation sequencing data according to the reference genome annotation data to obtain promoter subregion methylation data, enhancement subregion methylation data and transcription factor binding site methylation data; performing dynamic sequence similarity calculation processing on the methylation data of the promoter region to obtain a first feature vector containing importance weight of the promoter region of the cancer-related gene; the methylation sites are classified according to the functions of the methylation sites in the transcriptional regulation pathway, so that the biological interpretation of the characteristics is improved, and the synergistic effect among different functional regions can be captured.
Owner:SHENZHEN RAPHA BIOTECHNOLOGY CO LTD

Methylation-based biological sex prediction

Methods and systems are disclosed for covariate prediction from methylation features. A system trains methylation state models that are configured to regress one or more methylation features at a genomic region based on covariates for a given sample. The system utilizes the methylation state models to determine information gain of genomic regions in predicting covariates of interest. The system may, based on the information gain, identify covariate-informative genomic regions. The system trains a covariate prediction model using non-cancer training samples with reported covariate label(s) and methylation features at a plurality of covariate-informative genomic regions. The system may deploy the covariate prediction model for sample swap detection. Additionally, the system may utilize prediction(s) from covariate prediction model(s) to serve as a feature to cancer classification.
Owner:GRAIL INC

Compositions and methods for preserving DNA methylation

The disclosure provides methods for storage solutions for preserving DNA methylation patterns over a period of time. The disclosure also provides for methods of using methylated DNA stored in such storage solutions.
Owner:CASE WESTERN RESERVE UNIV

Application of compound for regulating and controlling METTL3 target spot in preparation of anti-enterovirus medicine

The invention provides application of a compound for regulating and controlling an METTL3 target spot in preparation of an anti-enterovirus drug, and belongs to the field of biological medicine, the compound is AN-465 / 42162872, and the compound has a relatively strong anti-EV71 effect in both in-vitro and in-vivo infection models. An in-vitro cell experiment, EV71 infected C57BL / 6 suckling mouse model, m6A methylation sequencing and other methods are utilized to research the activity and potential action mechanism of anti-EV71, and the result shows that AN-465 / 42162872 can inhibit duplication of EV71 in a human RD cell strain in a dose-dependent manner under the condition of maintaining relatively good cell activity, so that the application of AN-465 / 42162872 in the preparation of the EV71 drug is developed. The action mechanism is mainly as follows: the methylation level of the 5002 adenine in the 2C region of EV71 nucleic acid is remarkably reduced by regulating the METTL3, so that virus replication is inhibited, and the METTL3 has relatively high anti-EV71 drug utilization value.
Owner:GUANGXI MEDICAL UNIVERSITY

Composition for detecting ovarian cancer and application thereof

The invention provides a composition for detecting ovarian cancer and application thereof, the composition comprises nucleic acid for detecting the methylation state of a target gene, and the target gene is one or more than two of a TFAP2E gene, a WNT10A gene and an IFFO1 gene. The invention also provides a kit comprising the composition, and application of the composition in preparation of the kit for in-vitro detection of ovarian cancer.
Owner:BIOCHAIN BEIJING SCI & TECH

Methods for assaying circulating tumor DNA

The present disclosure includes a method of comprising (a) obtaining cell-free DNA (cfDNA) from a sample from a subject; (b) selectively enriching subsets of the cfDNA from (a) or derivatives therefrom having one or more target regions to obtain enriched DNA, wherein the target regions are differentially methylated in cancer; (c) sequencing the enriched DNA from (b) to obtain sequence reads; and (d) partitioning a plurality of the sequence reads into two or more groups based on their methylation status and determining the fragment length distribution of the sequence reads in at least one of the groups.
Owner:NATERA INC

Application of reagent for detecting DNA methylation of RPL10 promoter region in preparation of sow pregnancy diagnosis product

The invention belongs to the technical field of biological diagnosis, and particularly relates to application of a reagent for detecting DNA methylation of an RPL10 promoter region in preparation of a sow pregnancy diagnosis product. Through methylation high-throughput sequencing of blood DNA of pregnant sows and non-pregnant sows, it is found that the methylation level of a gene promoter region of the ribosomal protein L10 in the early pregnancy stage of the sows is remarkably reduced. The methylation level of the pregnant sow RPL10 is analyzed by using MSP, BSP and qMSP methods, and meanwhile, the ROC curve analysis result also shows that the RPL10 has diagnostic value. The results show that the method for detecting the RPL10 gene in the pig blood sample can be an effective method for diagnosing the early pregnancy of pigs. According to the invention, a pregnancy diagnosis technology based on RPL10 promoter region DNA methylation is preliminarily established, pig pregnancy detection methods are enriched, and a reference is provided for further exploring the DNA methylation level and the regulation mechanism of the pig pregnancy early stage.
Owner:SHIHEZI UNIVERSITY